These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31114137)

  • 21. A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis.
    Xue Y; Qin X; Zhou L; Lin S; Wang L; Hu H; Xia J
    Clin Drug Investig; 2016 Dec; 36(12):985-992. PubMed ID: 27605258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.
    Sung JJ; Barkun A; Kuipers EJ; Mössner J; Jensen DM; Stuart R; Lau JY; Ahlbom H; Kilhamn J; Lind T;
    Ann Intern Med; 2009 Apr; 150(7):455-64. PubMed ID: 19221370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life.
    Takeshima F; Hashiguchi K; Onitsuka Y; Tanigawa K; Minami H; Matsushima K; Akazawa Y; Shiozawa K; Yamaguchi N; Taura N; Ohnita K; Ichikawa T; Isomoto H; Nakao K
    Med Sci Monit; 2015 Dec; 21():4111-21. PubMed ID: 26719012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs.
    Edwards SJ; Lind T; Lundell L
    Aliment Pharmacol Ther; 2006 Sep; 24(5):743-50. PubMed ID: 16918878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26121348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacies of lactulose plus live combined Bacillus subtilis and Enterococcus faecium capsules in the treatment of functional constipation: a multicenter, randomized, double blind, controlled trial].
    Li SR; Wang HH; Wu ZY; Liu RH; Tong MH; Wang CH; Wang RL; Zhao HC; Wei W
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(42):2955-60. PubMed ID: 23328283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26121347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26422095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity does not affect treatment outcomes with proton pump inhibitors.
    Sharma P; Vakil N; Monyak JT; Silberg DG
    J Clin Gastroenterol; 2013 Sep; 47(8):672-7. PubMed ID: 23442835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis.
    Zheng RN
    World J Gastroenterol; 2009 Feb; 15(8):990-5. PubMed ID: 19248200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
    Vasiliadis KV; Viazis N; Vlachogiannakos J; Sgouros SN; Stefanidis G; Archimandritis A; Karamanolis DG
    Am J Gastroenterol; 2010 Feb; 105(2):308-13. PubMed ID: 19809412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Johnson DA; Benjamin SB; Vakil NB; Goldstein JL; Lamet M; Whipple J; Damico D; Hamelin B
    Am J Gastroenterol; 2001 Jan; 96(1):27-34. PubMed ID: 11197282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of gastric acid suppression on probiotic colonization in a double blinded randomized clinical trial.
    Singh G; Haileselassie Y; Briscoe L; Bai L; Patel A; Sanjines E; Hendler S; Singh PK; Garud NR; Limketkai BN; Habtezion A
    Clin Nutr ESPEN; 2022 Feb; 47():70-77. PubMed ID: 35063245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial.
    Tan VP; Wong WM; Cheung TK; Lai KC; Hung IF; Chan P; Pang R; Wong BC
    J Gastroenterol; 2011 Jul; 46(7):906-12. PubMed ID: 21538030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    BMC Pediatr; 2010 Jun; 10():41. PubMed ID: 20540767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On-demand versus half-dose continuous therapy with esomeprazole for maintenance treatment of gastroesophageal reflux disease: A randomized comparative study.
    Cho JH; Koo JY; Kim KO; Lee SH; Jang BI; Kim TN
    Medicine (Baltimore); 2018 Oct; 97(43):e12732. PubMed ID: 30412065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prolonged PPI therapy in reflux esophagitis is sustainable].
    Storr M
    MMW Fortschr Med; 2015 Jun; 157(11):35. PubMed ID: 26049345
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
    Kinoshita Y; Kato M; Fujishiro M; Masuyama H; Nakata R; Abe H; Kumagai S; Fukushima Y; Okubo Y; Hojo S; Kusano M
    J Gastroenterol; 2018 Jul; 53(7):834-844. PubMed ID: 29188387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study).
    Lu B; Zhang L; Wang J; Wang B; Zou X; Fei G; Chen D; Wang X; Wu B; Zou D
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1722-1727. PubMed ID: 29575167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.